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Sustained ventricular tachycardia or fibrillation that de•
velops during the early recovery period after acute myo•
cardial infarction is a common clinical problem whose 
management remains controversial. Fifty-three patients 
who survived an initial episode of sustained ventricular 
tachycardia or fibrillation occurring between 3 and 60 
days (mean ± SD 21 ± 16) after myocardial infarction 
were evaluated. Most of these patients had had a large 
(peak creatine kinase = 1,729 ± 882 IV) complicated 
infarction. Forty-two (79%) of the 53 patients had had 
repetitive sustained ventricular arrhythmias and the 
condition of 19 of these could not be stabilized with drug 
therapy. Twenty-eight patients received medical therapy 
only. Twenty-four survived and were discharged from 
the hospital. 
Twenty-five patients underwent infarctectomy or 
aneurysmectomy either on an emergency basis (16 pa•
tients) or electively because of coexistent heart failure or 
Mortality after acute myocardial infarction occurs in several 
phases. Death before hospitalization is usually due to the 
development of ischemically mediated ventricular tachyar•
rhythmias (I). During the first 48 hours after hospitalization, 
mortality due to unexpected ventricular arrhythmias is low 
and most deaths are due to either cardiogenic shock or 
mechanical complications. During the later hospital period 
and the first months after discharge, ventricular arrhythmias 
are the most common cause of mortality. Although the prev•
alence of these arrhythmias is related to the extent of left 
ventricular damage, they often occur unexpectedly in pa•
tients previously thought to be in stable condition (2,3). 
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angina (9 patients). Intraoperative mapping was at•
tempted in these patients but was completely successful 
in only 13 (52 %). Operative mortality was 16% with all 
deaths occurring in patients who were in shock before 
surgery. Five of 21 surgically treated survivors required 
long-term antiarrhythmic therapy. Twenty-one of 24 pa•
tients medically treated remain alive and well after 
15 ± 10 months of follow-up. Nineteen of 21 surgically 
treated patients remain alive and well after 17.9 ± 11 
months. One of these patients required reoperation for 
severe mitral regurgitation. 
These results confirm the poor medical prognosis of 
sustained ventricular tachyarrhythmias that present 
during the first 2 months after myocardial infarction but 
demonstrate that an acceptable rate of survival can be 
achieved with a combined medical and surgical approach 
to therapy. 
(J Am Coli CardioI1985;6:759-68) 
Even if the patient is resuscitated from the initial episode, 
the appearance of sustained ventricular tachycardia or ven•
tricular fibrillation during the first 2 months after myocardial 
infarction has been associated with an ominous long-term 
prognosis and a reported I year mortality rate of 50 to 80% 
(3-8). Despite this high mortality rate, firm guidelines re•
garding the appropriate medical or surgical approach, or 
both, to these patients have not been established. 
During the past 3 years we have evaluated 53 patients 
who survived an initial sustained episode of ventricular 
tachycardia or ventricular fibrillation 2 days to 2 months 
after an acute myocardial infarction. In this report we de•
scribe the clinical and electrophysiologic characteristics of 
these patients and the results of therapy using a combined 
medical and surgical approach. 
Methods 
Patients. The study group comprised 53 consecutive pa•
tients evaluated by the clinical electrophysiology service at 
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the University of Virginia between December 1981 and 
December 1984 who had survived one or more episodes of 
sustained ventricular tachycardia or ventricular fibrillation 
occurring 2 days to 2 months after an acute myocardial 
infarction. Patients whose arrhythmia was due to docu•
mented extension of their infarction or to progressive cir•
culatory failure were excluded. Ten patients with this syn•
drome who were initially cared for at the University of 
Virginia Hospital and 43 patients who were referred after 
initial evaluation at other institutions are included. There 
were 43 men and 10 women aged 61 ± 10 years (mean ± 
SD) in the group. Pertinent clinical data describing these 
patients are included in Tables I and 2. 
Electrophysiologic studies. These studies were per•
formed in the fasting state at least 24 to 48 hours after 
discontinuation of prior antiarrhythmic therapy whenever 
feasible. Three or four quadripolar electrode catheters were 
inserted percutaneously into femoral or antecubital veins, 
or both, and then advanced to the heart under fluoroscopic 
guidance. The catheters were then positioned in the high 
right atrium, across the tricuspid valve adjacent to the bundle 
of His, in the right ventricular apex and, when indicated, 
in the coronary sinus. Intracardiac recordings were filtered 
between 30 and 500 Hz and displayed on a multichannel 
oscilloscope (Electronics for Medicine, VR-16). The signals 
were stored on FM magnetic tape (Honeywell, model 101) 
and reproduced for analysis on a high-speed ink-jet recorder 
(Mingograf 16, Siemens Medical Electronics) at paper speeds 
of 50 to 200 mmls. Programmed cardiac stimulation was 
performed using a constant current stimulator (Bloom DTU-
101) that delivered rectangular pulses of 2 ms duration at 
four times diastolic threshold. In 16 patients with ventricular 
tachycardia that was well tolerated hemodynamically, en•
docardial catheter mapping (9) during spontaneous or stim•
ulation-induced ventricular tachycardia was performed either 
at their initial study or on a subsequent day. 
The ventricular stimulation protocol employed has been 
described previously (10). Briefly it includes single, double 
and triple extrastimuli delivered decrementally during sinus 
rhythm and ventricular pacing at 600 (or 500) and 400 ms, 
respectively. If no sustained ventricular arrhythmia was in•
itiated by pacing from the right ventricular apex, the catheter 
was repositioned in the right ventricular outflow tract and 
the stimulation protocol repeated. 
In those patients in whom programmed ventricular stim•
ulation did not reproduce their clinical arrhythmia, repeat 
ventricular stimulation was carried out on a separate day to 
confirm the initial findings. Serial electrophysiologic testing 
was performed to assess the effects of medical or surgical 
therapy using a single electrode catheter positioned within 
the right ventricle. Studies in patients who underwent sur•
gery were performed 7 to 14 days postoperatively. 
Operative techniques. All patients were anesthetized 
with nitrous oxide, intravenous narcotics and muscle relax-
lACC Vol. 6, No.4 
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ants. Normothermic cardiopulmonary bypass was instituted 
with the perfusate temperature maintained at 38 to 40°C. 
Three reference pairs of stainless steel electrodes were su•
tured to the right and left ventricular epicardial surfaces for 
recording and stimulation as described. Endocardial re•
cordings were obtained using a finger-held ring electrode 
(Elecath). Thirteen patients had received one or more an•
tiarrhythmic drugs within 24 hours of their operation but in 
each of these patients, ventricular tachycardia had occurred 
spontaneously or in response to stimulation with the patient 
on that dru~ regimen. If no arrhythmia was initiated with 
ventricular stimulation using any pair of epicardial elec•
trodes, isoproterenol (2 to 6 I-Lgimin) was infused intrave•
nously and the ventricular stimulation protocol repeated. If 
only ventricular fibrillation or polymorphic ventricular 
tachycardia was induced, procainamide (500 to 1,000 mg) 
or lidocaine (75 to 150 mg) was administered in an attempt 
to produce a tachycardia of uniform configuration suitable 
for mapping. 
We defined a satisfactory mapping study as one in which 
an area of endocardium with electrical activity preceding 
the onset of the QRS complex on the surface electrocardio•
gram during a tachycardia that resembled the clinically doc•
umented arrhythmia was identified (11). If a satisfactory 
map was obtained, endocardial resection as described by 
Horowitz et al. (11) was performed at the site demonstrating 
earliest electrical activity. After completion of the resection, 
ventricular stimulation was repeated to confirm that the tis•
sue removed caused the arrhythmia. If the same or another 
morphologically distinct tachycardia was initiated, mapping 
was repeated and further endocardial excision performed. 
The induction of only ventricular fibrillation or polymorphic 
ventricular tachycardia at this point was not considered to 
be significant. 
In those patients in whom a satisfactory map could not 
be obtained, alternate procedures were used. Limited re•
sections were carried out in regions identified during pre•
operative catheter mapping in the first two such patients. In 
subsequent patients an extended subendocardial resection 
that included all visible areas of subendocardial scar around 
the border of the scar was performed (2). If a papillary 
muscle contained scar, either the muscle was resected (one 
patient) and the mitral valve replaced or the area was ablated 
by cryothermic lesion (seven patients). All subendocardial 
resections were performed before aortic cross-clamping and 
induction of hypothermia. 
Definitions. An episode of spontaneous or stimulation•
induced arrhythmia was considered to be sustained if it was 
greater than 30 seconds in duration or required eatlier ter•
mination by countershock or ventricular pacing because of 
hemodynamic deterioration. Ventricular tachycardia was 
defined as nonsustained if it was between 10 beats and 30 
seconds in duration. A patient was considered to have in•
ducible ventricular tachycardia at electrophysiologic study 
Table 1. Summary of 28 Medically Treated Patients 
Age(yr)/ 
Case Sex 
2 
3 
4 
5 
6 
7 
8 
9 
10 
II 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
58/M 
42/M 
58/M 
60/M 
69/M 
65/M 
4 11M 
35/M 
55/M 
82/F 
49/M 
65/M 
7l1F 
59/M 
8l1F 
61/M 
73/F 
43/M 
57/M 
57/M 
64/M 
60/M 
70/M 
52/M 
6 11M 
58/F 
5 11M 
66/F 
Peak 
CK 
(IU) 
MI Previous Early 
Location MI Complications 
1,863 Ant 
2,596 Ant 
387 Inf 
2,275 Inf 
1,600 Inf 
2,645 Inf 
3,200 Inf 
2,000 Ant 
2,750 Ant 
180 Ant 
1,008 Ant 
330 Inf 
1,152 Ant 
1,000 Inf 
1,844 Ant 
916 Inf 
1,070 Inf 
2,194 Ant 
771 Ant 
NA Inf 
384 NA 
2,045 Inf 
800 Inf 
2,800 Inf 
NA Inf 
3,200 Ant 
1,795 Ant 
1,252 Ant 
No 
No 
No 
No 
Yes 
Yes 
No 
No 
No 
No 
Yes 
No 
No 
Yes 
No 
No 
No 
No 
Yes 
No 
Yes 
No 
Yes 
Yes 
No 
No 
Yes 
No 
N 
VF,BBB 
AP, CABO(3) 
N 
N 
AP, CABO(3) 
N 
N 
CHF, BBB 
SVT 
CHB 
N 
N 
N 
N 
PE, BBB 
N 
BBB 
N 
N 
N 
N 
N 
VF 
VSD 
N 
PE 
BBB 
Number 
of 
Arteries 
With 
>70% 
Stenosis 
3 
1 
3 
2 
3 
2 
2 
2 
3 
3 
1 
3 
3 
2 
2 
3 
3 
3 
Number 
L VEF Days of Clinical 
(%) to VT Episodes* Arrhythmia Arrhythmia 
42 
33 
33 
40 
70 
40 
45 
35 
40 
30 
20 
25 
NA 
31 
25 
40 
55 
14 
54 
60 
27 
51 
43 
74 
38 
32 
10 
25 
5 
14 
36 
14 
31 
7 
3 
7 
15 
29 
7 
3 
6 
13 
43 
16 
38 
4 
17 
16 
7 
10 
10 
9 
8 
10 
19 
14 
1 
3 
8 
10 
1 
2 
2 
4 
2 
4 
3 
10 
3 
2 
3 
3 
I 
3 
10 
7 
3 
4 
SusVT 
VF 
VF 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
VF 
SusVT 
SusVT 
VF 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
VF 
VF 
SusVT 
VF 
VF 
VF 
No VT 
No VT 
VF 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
VF 
No VTt 
SusVT 
VF 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
VF/No VT 
NSPVT 
VF 
SusVT 
EPS 
CL 
>200 
250 
220 
240 
320 
220 
>200 
370 
>200 
390 
390 
300 
500 
250 
260 
270 
280 
210 
>200 
320 
Initiation 
1VES 
2VES 
2VES 
3VES 
1VES 
3VES 
3VES 
1VES 
3VES 
2VES 
2VES 
2VES 
2VES 
3VES 
2VES 
2VES 
2VES 
3VES 
2VES 
2VES 
Early 
Clinical 
Course 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Stable 
Unstable 
Unstable 
Unstable 
Discharge 
Medication Outcome 
A&W 
A&W 
Pa A&W 
Amio A&W 
Amio A&W 
Amio A&W 
PA A&W 
Amio A&W 
Amio/Quin A&W 
A&W 
Amio A&W 
Amio/Quin A-VT 
D-VR 
Amio 
Amio 
Amio 
Amio 
Quin 
Quin 
Amio 
Amio/PA 
Quin 
Pa 
Amio 
SCD 
D-CVA 
D-MI 
A&W 
A&W 
A&W 
A&W 
A&W 
A&W 
A&W 
A&W 
A&W 
D-early 
D-early 
D-early 
*Maximum of 10; tsustained ventricular tachycardia on quinidine. Amio = amiodarone; Ant = anterior; AP = angina pectoris; A-VT = alive with ventricular 
tachycardia; A&W = alive and well; BBB = bundle branch block; CABO = coronary artery bypass grafts (number of grafts); CHB = complete heart block; CHF = 
congestive heart failure: CK = creatine kinase (normal range 30 to 110 IU); CL = cycle length; CV A = cerebrovascular accident; D = death; EPS = electrophysiologic 
study; F = female; Inf = inferior; LVEF = left ventricular ejection fraction; M = male; MI = myocardial infarction; N = none; NA = not available; NSPVT = 
non sustained polymorphic ventricular tachycardia; Pa = procainamide; PE = pulmonary edema; Quin = quinidine; SCD = sudden cardiac death; SVT = supraventricular 
tachycardia; SusVT = sustained ventricular tachycardia; YES = ventricular extrastimuli; VF = ventricular fibrillation; VR = ventricular rupture; VSD = ventricular 
septal defect; VT = ventricular tachycardia. 
Length of 
Follow-Up 
(days) 
233 
223 
259 
77 
134 
174 
278 
294 
75 
83 
133 
327 
226 
259 
362 
973 
1,148 
698 
481 
559 
582 
500 
881 
861 
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Table 2. Summary of 25 Surgically Treated Patients 
Age(yr)1 Peak MI Previous Early 
Case Sex CK Location MI Complications 
I 361M 2,060 Ant No N 
2 67/M 1,528 Ant No N 
3 73/F 2,247 Ant No CHF 
4 57/M 681 Inf Yes PE, BBB 
5 65/M 1,734 Inf Yes BBB,AP 
6 76/M 880 Ant No CHF 
7 46/M 1,600 Ant No AP 
8 70/F 2,900 Ant No CHF 
9 68/F 1,034 Inf No CHF 
10 82/F 440 Ant Yes PE 
11 65/M NA Ant No PE 
12 73/F 528 Ant No CHF 
13 62/M 2,416 Ant No CHF 
14 52/M 3,306 Ant Yes CHF 
15 6 11M 2,070 Ant Yes VF,CHF 
16 49/M 3,580 Ant No CHF 
17 62/M 2,410 Ant No VF 
18 75/M 402 Ant Yes CHF 
19 55/M 2,300 Ant Yes N 
20 52/M 3,170 Ant No CHF 
21 55/M 826 Ant No PE 
22 54/M 2,500 Ant No N 
23 55/M 2,250 Ant No PE,BBB 
24 50/M 2,000 Ant No N 
25 41/M 1,600 Ant No PE, CHB 
Number of 
Arteries 
With 
>70% LVEF 
Stenosis (%) 
49 
41 
I 12 
3 28 
3 17 
2 50 
2 25 
2 20 
48 
2 19 
2 28 
16 
18 
3 22 
3 22 
25 
2 48 
2 40 
2 16 
3 43 
I 45 
2 18 
I 29 
3 61 
20 
Days 
to VT 
18 
27 
57 
7 
12 
10 
49 
15 
58 
34 
43 
16 
10 
33 
17 
6 
5 
11 
10 
44 
49 
15 
12 
14 
52 
Number of 
Episodes * 
2 
3 
2 
2 
10 
3 
2 
10 
10 
3 
3 
10 
10 
.4 
6 
10 
10 
3 
10 
10 
10 
10 
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Clinical 
Arrhythmia 
SusVT 
SusVT 
SusVT 
VF 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
VF 
VF 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
SusVT 
VF 
SusVT 
*Maximum of 10. Cryo = cryoablation; LV A = left ventricular aneurysmectomy; MVR = mitral valve replacement; other abbreviations as in 
Table I. 
if either sustained or nonsustained ventricular tachycardia 
was reproducibly initiated by programmed ventricular stim•
ulation as described previously. For the purpose of this 
report, patients who had a systolic blood pressure of 95 mm 
Hg or less associated with systemic hypoperfusion are de•
scribed as having been in shock. 
Results 
Initial presentation. The first episode of ventricular 
tachycardia or ventricular fibrillation occurred 21 ± 16 days 
(range 3 to 58) after the onset of symptoms of myocardial 
infarction. In 20 (38%) of 53 patients, the arrhythmia oc•
curred before hospital discharge while the remaining 33 
patients developed their arrhythmia as outpatients. In 40 
(75%) of 53 patients, monomorphic ventricular tachycardia 
was the first arrhythmia documented by electrocardiogram. 
The remaining 13 patients had ventricular fibrillation at the 
time of presentation. Forty-four of 53 patients required di•
rect current cardioversion or countershock for termination 
of the initial episode. In nine patients, the arrhythmia ter•
minated either spontaneously or after intravenous admin•
istration of one or more antiarrhythmic drugs. Nineteen 
patients (36%) were receiving antiarrhythmic drug therapy 
at the time of their first sustained episode of arrhythmia. 
These drugs had been prescribed because of previously doc•
umented ventricular ectopic activity. Twenty-seven patients 
were receiving digoxin and one patient was receiving a beta•
adrenergic blocking agent. Plasma concentrations of these 
agents, when measurements were available, were within the 
desired therapeutic range. In 19 patients, including almost 
all who presented with hemodynamically well tolerated 
tachycardia, the initial clinical diagnosis had been either 
supraventricular tachycardia or atrial flutter with aberrant 
intraventricular conduction. This error frequently delayed 
initiation of appropriate therapy. 
Characteristics of the preceding infarction. Thirty•
seven patients had no previous history of acute myocardial 
infarction. Sixteen patients had experienced one prior myo•
cardial infarction. Considering the current illness only, 35 
patients had an anterior infarct; 17 had an inferior infarct 
and in 1 patient with chronic left bundle branch block and 
two areas of akinesia, the site of the more recent infarct 
was undetermined. In most patients, the infarct had been 
associated with evidence of substantial myocardial damage 
with a peak creatine kinase (CK) level of 1,729 ± 882 IU 
lACC Vol. 6, No.4 
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Table 2. (continued) 
Case Arrhythmia 
I SusVT 
2 SusVT 
3 SusVT 
4 SusVT 
5 SusVT 
6 SusVT 
7 SusVT 
8 SusVT 
9 SusVT 
10 
II 
12 No VT 
13 Sus VT 
14 
15 
16 SusVT 
17 SusVT 
18 SusVT 
19 
20 SusVT 
21 SusVT 
22 SusVT 
23 SusVT 
24 
25 SusVT 
EPS 
CL 
320 
260 
370 
300 
320 
250 
320 
420 
430 
240 
370 
260 
260 
210 
470 
380 
320 
270 
Early 
Clinical 
Course Time to 
Initiation (days) Operation 
IVES Stable 29 
2VES Stable 96 
IVES Stable 103 
3VES Stable 102 
2VES Stable 20 
2VES Stable 21 
2VES Stable 57 
IVES Stable 52 
IVES Stable 183 
Unstable 61 
Unstable 76 
Unstable 29 
3VES Unstable 36 
Unstable 36 
Unstable 20 
IVES Unstable 22 
IVES Unstable 20 
2VES Unstable 27 
Unstable 19 
2VES Unstable 71 
IVES Unstable 60 
IVES Unstable 43 
IVES Unstable 19 
Unstable 21 
2VES Unstable 54 
(normal 30 to 110). During the first 48 hours after the onset 
of symptoms, 32 (61%) of 53 patients manifested one or 
more significant complications. These included early ven•
tricular fibrillation in 4 patients, pulmonary edema requiring 
intubation in 8 patients, less severe congestive heart failure 
in 12 patients, new bundle branch block in 8 patients and 
complete heart block in 2 patients. Two patients underwent 
coronary artery bypass grafting in the early postinfarction 
period because of persistent chest pain and then developed 
sustained ventricular tachycardia during an otherwise un•
eventful postoperative period. A single patient developed 
incessant, monomorphic ventricular tachycardia and a ven•
tricular septal defect 8 days after infarction. He underwent 
surgery for repair of his ventricular septal defect, nondi•
rected posterior aneurysmectomy and coronary artery bypass 
grafting at another institution and was later referred to our 
hospital when ventricular tachycardia recurred after surgery. 
Clinical course after resuscitation. Patients could be 
separated into two groups on the basis of early response to 
antiarrhythmic therapy after resuscitation from the initial 
episode of ventricular tachycardia or fibrillation (Fig. I). 
Thirty-four patients were considered to be in stable condi•
tion. Eleven patients experienced only a single episode of 
either ventricular tachycardia or fibrillation. However, I of 
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Length of 
Discharge Follow-up 
Operation Medication Outcome (days) 
LVA A&W 170 
LVA A&W 586 
LVA/Cryo A&W 103 
LV A/CABG(3) A&W 1,147 
LV A/CABG(3) A&W 330 
LV A/CABG(2) A&W 347 
LV A/CABGICryo Pa A&W 316 
LV AICABG(2) A&W 1,057 
LV A/CABG(3) A&W 1,146 
LV A/CABG(2) D-OP 
LV A/CABG(2) D-OP 
LVA Pa SCD 229 
LV A/CABG(I) Amio D-CHF 252 
LV A/CABG(3)/Cryo D-OP 
LV A/CABG(2)1Cryo D-OP 
LVA/Cryo Late MVR 557 
LV A/CABG(2)/Cryo A&W 452 
LV A/CABG( I )/Cryo Amio A&W 689 
LV A/CABG(2) Amio A&W 1,061 
LV A/CABG(2)/MVR A&W 357 
LVA A&W 452 
LV A/CABG(2) A&W 487 
LVA A&W 174 
LV A/CABG(3) A&W 320 
LV A/CABG(I) A&W 807 
these I I was followed up for only 4 days after developing 
ventricular tachycardia before she died from rupture of the 
left ventricular free wall. An additional 23 patients had more 
than one episode but the interval between episodes was 
usually greater than 72 hours and the patients were nor•
motensive and free of severe symptomatic heart failure be•
tween episodes. Nine (26%) of the 34 patients in stable 
condition subsequently underwent surgery because of per•
sistent limiting angina or heart failure. The operations in 
these patients were performed 74 ± 50 days (range 20 to 
183) after infarction. 
Figure 1. Flow diagram illustrating the early clinical course in 
all 53 patients. EP = electrophysiologic study. 
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The remaining 19 patients had an unstable clinical course. 
In these patients ventricular tachycardia or fibrillation oc•
curred in repetitive or incessant fashion and resuscitation 
from a subsequent episode was complicated by refractory 
heart failure or hypotension. Three patients in this group 
died when they could not be successfully resuscitated from 
a repeat cardiac arrest. The remaining 16 patients, 12 of 
whom were in shock immediately before surgery, underwent 
emergency surgery in an attempt to control their arrhyth•
mias. Operations in these patients were performed 35 ± 18 
days after infarction and 15 ± 9 days after the first sustained 
ventricular arrhythmia. 
Anatomic findings. As part of their clinical manage•
ment, 50 of the 53 patients underwent cardiac catheterization 
including coronary arteriography and left ventriculography. 
In these patients 1. 9 ± 0.8 coronary arteries had greater 
than 70% stenosis and the left ventricular ejection fraction 
was 33 ± 16%. There was no significant difference in the 
number of diseased coronary arteries when the patients in 
stable or unstable condition were compared (1.9 in both 
groups) but left ventricular ejection fraction was lower in 
the patients in unstable condition (38 ± 15 versus 28 ± 
13%, p < 0.05). 
Electrophysiologic studies. These studies were per•
formed without antiarrhythmic drug therapy in 43 of 53 
patients. The clinical status in 10 patients never permitted 
drug withdrawal for baseline electrophysiologic study. In 
38 (88%) of these 43 patients, programmed ventricular stim•
ulation resulted in the initiation of a ventricular arrhythmia 
(sustained ventricular tachycardia in 33, ventricular fibril•
lation in 4 and nonsustained ventricular tachycardia in 1) 
consistent with or identical to that observed clinically. These 
arrhythmias were initiated by a single ventricular extrasti•
mulus in 12 patients, double extrastimuli in 19 patients and 
triple extrastimuli in 7 patients. Cycle lengths during in•
duced ventricular tachycardia ranged from 210 to 500 ms 
(299 ± 78). One patient with a single episode of sustained 
monomorphic ventricular tachycardia 10 days after infarc•
tion had ventricular fibrillation induced by three extrastimuli 
during ventricular pacing at his first study and no arrhythmia 
during a repeat study. One patient had no arrhythmia during 
an initial study and sustained ventricular tachycardia in re•
sponse to stimulation after quinidine (plasma concentration 
3.5 JLg/ml) , a drug she had been receiving at the time of 
her initial episode. In three patients with a negative response 
to stimulation at both initial and repeat studies the first 
episode of arrhythmia occurred 5, 14 and 16 days, respec•
tively, after infarction. One of these three had multiple 
episodes of sustained ventricular tachycardia with and with•
out drug therapy before and after the negative electrophys•
iologic study. Left ventricular stimulation performed in this 
one patient also failed to initiate ventricular tachycardia. 
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Long-term medical therapy. Twenty of the 53 patients 
were discharged and have been followed up on medical 
therapy only. Medications in this group include amiodarone 
in 12 patients, quinidine in 3 patients, procainamide in 3 
patients and amiodarone plus either procainamide or quin•
idine in 3 patients. Ventricular tachycardia was suppressed 
at the time of final electrophysiologic study in 15 patients 
and was still inducible in 5 patients, all of whom were 
discharged on therapy that included amiodarone. During a 
follow-up period of 15 ± 10 months, there have been one 
sudden death, two non sudden deaths and one nonfatal ep•
isode of ventricular tachycardia among these 20 patients. 
Both patients with recurrent arrhythmias were receiving either 
amiodarone or amiodarone plus quinidine and the arrhyth•
mias were still inducible at their final electrophysiologic 
study. 
Three patients with negative or inconsistent baseline elec•
trophysiologic studies and the patient with an apparent drug•
induced arrhythmia have been followed up while not on 
specific therapy for ventricular arrhythmias. All four remain 
alive and well after 9.7 ± 6 months of follow-up. 
Surgical procedures: intraoperative mapping. The re•
sults of intraoperative electrophysiologic mapping in the 25 
patients who underwent surgery are summarized in Table 
3. Endocardial activation sequence maps adequate for lo•
calization of a probable site of origin of an induced ven•
tricular tachycardia that was similar in configuration to one 
observed clinically were obtained in only 13 (52%) of the 
25 patients. Several factors accounted for this low rate of 
success. In three patients, no arrhythmia could be induced 
with any form of programmed ventricular stimulation. In 
one of these three the arrhythmia was also non inducible at 
both pre- and postoperative studies despite recurrent epi•
sodes of sustained ventricular tachycardia. Ventricular fi•
brillation was the only arrhythmia produced with ventricular 
stimulation in five patients. In nine patients, multiple mor•
phologically distinct tachycardias were initiated and not all 
were completely mapped. In five of these nine patients, 
however, an adequate map of the tachycardia that most 
closely resembled the clinical arrhythmia was obtained. 
Results of surgery. The surgical procedures performed 
in the 25 patients in this series are listed in Table 2 and 
Table 3. Summary of Intraoperative 
Electrophysiologic Findings 
Clinical VT initiated and mapped 
(other VTs also mapped) 
Clinical VT not initiated 
Multiple nonclinical VT 
VF only 
No arrhythmia 
VF = ventricular fibrillation; VT = ventricular tachycardia. 
13 
(5) 
12 
4 
5 
3 
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illustrated in Figure 2. Two patients could not be weaned 
from cardiopulmonary bypass and two died with circulatory 
failure in the immediate postoperative period. These four 
patients were operated on 20, 36, 61 and 76 days, respec•
tive1y, after infarction and all were in shock before their 
operation. Operative mortality could not be related to early 
timing of operation after infarction since 11 of 12 patients 
who underwent operation within 30 days after infarction 
survived. Sustained ventricular tachycardia spontaneously 
recurred postoperatively in four patients but was eventually 
suppressed with drug therapy in all but one. Three of four 
patients had incomplete or unsuccessful intraoperative map•
ping. In three patients, sustained ventricular tachycardia 
could be initiated at postoperative electrophysiologic study 
but the tachycardia was different in both rate and configu-
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ration from that observed before operation. Two of these 
three patients had adequate mapping of their clinically ob•
served arrhythmia, and two were discharged without an•
tiarrhythmic therapy. 
During a follow-up period of 17.9 ± 11 months two 
deaths occurred in the 20 patients who survived the im•
mediate perioperative period. One patient whose postop•
erative arrhythmias were never fully controlled died sud-
Figure 2. Patient 3 (Table 2). Typical angiographic and operative 
findings. The top panels demonstrate a large anteroapical aneu•
rysm on left ventriculography. In the bottom panel, the aneurysm 
has been opened and an initial endocardial resection performed. 
When ventricular tachycardia was still inducible, the resection was 
extended to include all visible subendocardial scar (dotted line). 
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denly and one patient died of progressive circulatory failure. 
Another patient required mitral valve replacement when se•
vere mitral regurgitation developed. In this patient, cryoab•
lation was performed on a visibly scarred anterior papillary 
muscle but previously mild mitral regurgitation worsened 
during the postoperative period. 
Discussion 
Clinical implications. Our data demonstrate that an ag•
gressive protocol for evaluation and subsequent medical and 
surgical management can result in the acceptable survival 
rate in patients who develop sustained ventricular tachyar•
rhythmias in the early postinfarction period (Fig. 3). Initial 
control of arrhythmia with antiarrhythmic drug therapy was 
achieved in 64% of our patients. In many, the use of amio•
darone may have contributed to this improvement over re•
stilts in previous series in which this agent was usually not 
used. However, in more than one-third of our patients elec•
trical stability could not be achieved pharmacologically. An 
aggressive surgical approach in 16 patients with acute insta•
bility allowed salvage of 12. Surgical therapy also played 
a major role in the treatment of nine additional patients who 
were operated on primarily for heart failure or angina but 
who also had ventricular tachycardia; all of these patients 
survived operation. Thus the overall surgicai mortality in 
this series was only 17% with all early deaths occurring in 
patients in shock at the time of their operation. 
Previous studies. Previous studies have consistently re•
ported that patients who develop sustained ventricular ar•
rhythmias early after infarction have an extremely high short-
Figure 3. Life-table analysis of survival in 53 cases. The two 
curves show survival for all patients and those surviving hospi•
talization only. VT = ventricular tachycardia. 
75 \ 
g' All~~------------------------
":; Patients (N::531 
.~ 
:l 
(f) 
* 50 
Q) 
.<: 
o 
"3 
E 
" u 
25 
200 
• Medically Treated Potients 
x Surgically Treated Patients 
400 600 
Follow-up (Days After VT) 
800 
Pohenl' AI (34) (16) (II) (8) 
Risk 
JACC Vol. 6, No.4 
October 1985:759-68 
term mortality rate with medical treatment alone. Wilson 
and Adgey (3) reported that 19% of patients who manifested 
ventricular fibrillation or cardiac arrest during the late in•
hospital phase of myocardial infarction failed to survive their 
first episode and 53% of those initially resuscitated went on 
to have repeat episodes while still in the hospital. Only 57% 
of the initial group survived to hospital discharge and 27% 
of these died within 1 year. Wellens et al. (7) reported an 
80% 1 year mortality rate in a group of medically treated 
patients who developed sustained ventricular tachycardia 
within the first 8 weeks after acute infarction. Thirteen (61 %) 
of 21 medically managed patients in the series described by 
Marchlinski et al. (8) died during follow-up. 
Despite these poor results with conventional medical 
therapy, it has been thought that surgery for ventricular 
arrhythmias occurring within this time frame was relatively 
contraindicated because of an unacceptable mortality rate. 
Lie et al. (6) reported a 50% mortality rate in six patients 
with sustained ventricular arrhythmias who underwent aneu•
rysmectomy or infarctectomy during this period. Eight (47%) 
of 17 patients described by Wald et al. (13) and 10 (63%) 
of 16 patients in a series reported by Buda et al. (14) died 
during or shortly after surgery. Marchlinski et al. (8) re•
ported long-term survival in only 4 (33%) of 12 patients 
who underwent electrophysiologically guided surgery for 
sustained ventricular tachycardia after myocardial infarction. 
In contrast, two recent studies have yielded somewhat 
more encouraging results. Garan et al. (15) reported that 11 
of 21 patients who presented with sustained ventricular 
tachycardia within 3 to 15 days of acute myocardial infarc•
tion responded to medical therapy and that 8 of those 10 
who failed to respond were sucessfully treated with map•
guided infarctectomy. Seven of these eight patients were 
long-term survivors. Miller et al. (16) described a 12% 
mortality rat yin a series of patients with sustained ventric•
ular arrhythmias operated on within 4 months after infarc•
tion. Our data are in agreement with the results of these 
latter investigators. 
Possible limitations. Although our study group was made 
up of a consecutive series of patients evaluated at one in•
stitution for a single problem, the data obtained may not be 
totally applicable to all patients who develop ventricular 
tachycardia or ventricular fibrillation in the early months 
after myocardial infarction. Most of our patients were re•
ferred from other hospitals and in many cases referral was 
made only after one or more recUrrences of ventricular 
tachycardia or fibrillation. However, although only 10 pa•
tients received their primary care at our hospital, 5 of these 
10 had multiple episodes; only 3 responded to conventional 
antiarrhythmic drugs and 2 of the remaining 7 patients re•
quired surgery. These latter observations suggest that even 
in a nonreferral population, the development of a sustained 
ventricular arrhythmia within 2 months of myocardial in-
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farction is associated with a poor prognosis unless a prompt, 
aggressive evaluation is carried out, 
Role of electrophysiologic study. Ventricular tachy•
cardia or fibrillation was initiated by programmed ventric•
ular stimulation in 38 (88%) of 43 patients not receiving 
antiarrhythmic therapy, In one additional patient, clinical 
episodes of ventricular tachycardia appeared to be related 
to a pro arrhythmic effect of an antiarrhythmic drug, The 
arrhythmias in the four other noninducible patients all pre•
sented within the first 16 days after infarction, Three of 
these four patients are not receiving arrhythmic therapy 
and no further arrhythmias have occurred, Arrhythmias were, 
however, inducible in the 25 other patients who first de•
veloped ventricular tachycardia within 16 days after infarc•
tion, These observations suggest that although other mech•
anisms may be responsible for some arrhythmias that appear 
during this early period, most patients presenting with a 
sustained ventricular arrhythmia soon after myocardial in•
farction can be managed using an electrophysiologic ap•
proach similar to that used in other patients with chronic 
coronary artery disease, 
Limitations of mapping techniques. Despite the fa•
vorable influence of surgery on overall outcome in this se•
ries, the techniques we used for intraoperative electrophys•
iologic evaluation appeared to yield less than optimal data. 
The most common problems encountered were an inability 
to initiate ventricular tachycardia during operation, the in•
duction of only vel1tricular fibrillation and an inability to 
localize the site of origin for all tachycardias initiated by 
programmed stimulation. Our stimulation protocol failed to 
reproduce a clinically relevant arrhythmia in 8 of 24 patients 
intraoperatively. The reasons for this are uncertain but the 
effects of anesthesia, partial cardiopulmonary bypass and 
ventricular decompression after ventriculotomy may all con•
tribute to this problem. Another technique for inducing ar•
rhythmias intraoperatively is the use of alternating current 
as described by Mower et al. (17). However, our experience 
with this method in other patients has been disappointing. 
The initiation of multiple morphologically distinct ventric•
ular tachycardias that had not been previously documented 
was also a major problem. Whether these represent clinically 
significant potential arrhythmias or may safely be disre•
garded is an important question that we cannot answer on 
the basis of our current knowledge. Therefore, at present, 
we attempt to map and resect the sites of origin of any 
monomorphic ventricular tachycardia induced during sur•
gery. When complete mapping has not been possible, we 
have modified our surgical procedure to include an extended 
subendocardial resection of visible scar as was first proposed 
by Moran et al. (18). The use of this technique has permitted 
satisfactory clinical results to be achieved even though the 
demarcation of scar may not be as readily apparent early 
after infarction as it is in more chronic aneurysms. 
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Indications for and timing of operation. The optimal 
time for surgical treatment of arrhythmia after myocardial 
infarction remains controversial. Early reports described a 
high mortality rate for operations performed soon after in•
farction, and opinion developed (19) that surgery performed 
within the first 6 weeks after infarction was contraindicated. 
However, our data and the reports of Garan et al. (IS) and 
Miller et al. (16) suggest that this recommendation should 
be reevaluated. In particular, we believe that prolonged 
attempts to stabilize patients with medical therapy past some 
arbitrary point in time are not justified; during this period, 
many patients will have recurrent episodes of ventricular 
tachycardia or fibrillation that may result in either death or 
progressive hemodynamic deterioration. Therefore, we be•
lieve that each patient who develops a sustained ventricular 
tachyarrhythmia in the early weeks after infarction requires 
early invasive anatomic and electrophysiologic character•
ization. Surgical intervention should be prompt when an•
tiarrhythmic drug therapy fails or surgically remediable an•
gina and heart failure are concurrent problems. 
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